Analyst firms · Morgan Stanley · ZM

Morgan Stanley ZM price target and rating history

Zoom Communications Inc. (ZM) · Technology

Morgan Stanley rates Zoom Communications Inc. (ZM) Equal-Weight with a $85 price target, as of its latest action on Oct 21, 2025. It has published 3 rating actions on ZM since August 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a ZM price target in the last 12 months, the median target is $115.

Current rating
Equal-Weight
Price target
$85
Median target, all firms
$115
Actions on ZM
3

Morgan Stanley price target on ZM

$133$109$8520222023202420252026
Morgan Stanley price target on ZM, each point a stated target, August 2021 to October 2025. Targets before October 2022 (divided by 3) are adjusted for a stock split, going by the prior target Morgan Stanley restated.

Every Morgan Stanley rating on ZM

How other firms rate ZM

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
OppenheimerOutperform$130Oct 21, 2026
BofA SecuritiesBuy$130Aug 19, 2026
KeyBanc Capital MarketsSector WeightMay 22, 2026
Wolfe ResearchOutperform$115Feb 5, 2026
CitigroupBuy$106Jan 12, 2026
BTIGBuy$105Dec 17, 2025

Questions about Morgan Stanley and ZM

What is Morgan Stanley's price target for ZM?
Morgan Stanley's latest stated price target for Zoom Communications Inc. (ZM) is $85, from its action on Oct 21, 2025.
What is Morgan Stanley's rating on ZM?
Morgan Stanley rates ZM Equal-Weight, a neutral rating, as of Oct 21, 2025.
When did Morgan Stanley last change its view on ZM?
On Oct 21, 2025, Morgan Stanley resumes coverage at Equal-Weight, price target $85.
How does Morgan Stanley's ZM target compare with other analysts?
Across 5 firms with a ZM price target in the last 12 months, the median target is $115.

More ZM rating histories

All Morgan Stanley ratingsZM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.